Osaic Holdings’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.9K | Sell |
56
-1,381
| -96% | -$46.8K | ﹤0.01% | 6497 |
|
2025
Q1 | $45.7K | Sell |
1,437
-3,200
| -69% | -$102K | ﹤0.01% | 4768 |
|
2024
Q4 | $180K | Buy |
4,637
+12
| +0.3% | +$466 | ﹤0.01% | 3691 |
|
2024
Q3 | $208K | Buy |
4,625
+518
| +13% | +$23.3K | ﹤0.01% | 3615 |
|
2024
Q2 | $171K | Buy |
4,107
+2,578
| +169% | +$108K | ﹤0.01% | 3687 |
|
2024
Q1 | $69.6K | Buy |
1,529
+678
| +80% | +$30.9K | ﹤0.01% | 4491 |
|
2023
Q4 | $39.3K | Sell |
851
-297
| -26% | -$13.7K | ﹤0.01% | 5051 |
|
2023
Q3 | $46.7K | Buy |
1,148
+175
| +18% | +$7.12K | ﹤0.01% | 5036 |
|
2023
Q2 | $47.1K | Sell |
973
-34
| -3% | -$1.65K | ﹤0.01% | 4972 |
|
2023
Q1 | $49.6K | Buy |
1,007
+28
| +3% | +$1.38K | ﹤0.01% | 4952 |
|
2022
Q4 | $48.9K | Buy |
979
+208
| +27% | +$10.4K | ﹤0.01% | 4952 |
|
2022
Q3 | $39K | Hold |
771
| – | – | ﹤0.01% | 5065 |
|
2022
Q2 | $37K | Sell |
771
-257
| -25% | -$12.3K | ﹤0.01% | 5171 |
|
2022
Q1 | $63K | Sell |
1,028
-925
| -47% | -$56.7K | ﹤0.01% | 4913 |
|
2021
Q4 | $156K | Buy |
1,953
+105
| +6% | +$8.39K | ﹤0.01% | 4185 |
|
2021
Q3 | $162K | Buy |
1,848
+774
| +72% | +$67.9K | ﹤0.01% | 4096 |
|
2021
Q2 | $106K | Sell |
1,074
-757
| -41% | -$74.7K | ﹤0.01% | 4429 |
|
2021
Q1 | $165K | Buy |
1,831
+1,006
| +122% | +$90.7K | ﹤0.01% | 3913 |
|
2020
Q4 | $79K | Sell |
825
-200
| -20% | -$19.2K | ﹤0.01% | 4216 |
|
2020
Q3 | $74K | Hold |
1,025
| – | – | ﹤0.01% | 4033 |
|
2020
Q2 | $72K | Hold |
1,025
| – | – | ﹤0.01% | 3914 |
|
2020
Q1 | $51K | Buy |
+1,025
| New | +$51K | ﹤0.01% | 3940 |
|